Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 719

1.

Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.

Aanæs K.

J Cyst Fibros. 2013 Sep;12 Suppl 2:S1-20. doi: 10.1016/S1569-1993(13)00150-1.

2.

The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis.

Aanaes K, von Buchwald C, Hjuler T, Skov M, Alanin M, Johansen HK.

Am J Rhinol Allergy. 2013 Jan;27(1):e1-4. doi: 10.2500/ajra.2013.27.3829.

PMID:
23406585
3.

Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?

Aanaes K, Johansen HK, Skov M, Buchvald FF, Hjuler T, Pressler T, Hoiby N, Nielsen KG, von Buchwald C.

Rhinology. 2013 Sep;51(3):222-30. doi: 10.4193/Rhino12.207.

PMID:
23943728
4.

The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?

Banerjee D, Stableforth D.

Drugs. 2000 Nov;60(5):1053-64. Review.

PMID:
11129122
6.

Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response.

Johansen HK, Aanaes K, Pressler T, Nielsen KG, Fisker J, Skov M, Høiby N, von Buchwald C.

J Cyst Fibros. 2012 Dec;11(6):525-31. doi: 10.1016/j.jcf.2012.04.011. Epub 2012 May 15.

7.

Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.

De Baets F, Schelstraete P, Van Daele S, Haerynck F, Vaneechoutte M.

J Cyst Fibros. 2007 Jan;6(1):75-8. Epub 2006 Jun 21.

8.

Respiratory bacterial infections in cystic fibrosis.

Ciofu O, Hansen CR, Høiby N.

Curr Opin Pulm Med. 2013 May;19(3):251-8. doi: 10.1097/MCP.0b013e32835f1afc. Review.

PMID:
23449384
10.

Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection.

Hansen SK, Rau MH, Johansen HK, Ciofu O, Jelsbak L, Yang L, Folkesson A, Jarmer HØ, Aanæs K, von Buchwald C, Høiby N, Molin S.

ISME J. 2012 Jan;6(1):31-45. doi: 10.1038/ismej.2011.83. Epub 2011 Jun 30.

11.

Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.

Conway SP, Brownlee KG, Denton M, Peckham DG.

Am J Respir Med. 2003;2(4):321-32. Review.

PMID:
14719998
13.

Sinus biofilms in patients with cystic fibrosis: is adjusted eradication therapy needed?

Aanaes K, Eickhardt S, Johansen HK, von Buchwald C, Skov M, Høiby N, Bjarnsholt T.

Eur Arch Otorhinolaryngol. 2015 Sep;272(9):2291-7. doi: 10.1007/s00405-014-3322-x. Epub 2014 Oct 9.

PMID:
25297534
14.

Cystic fibrosis genotype and bacterial infection: a possible connection.

McManus TE, Beattie D, Graham C, Moore JE, Elborn JS.

Br J Biomed Sci. 2005;62(2):85-8.

PMID:
15997883
15.

Pathophysiology and management of pulmonary infections in cystic fibrosis.

Gibson RL, Burns JL, Ramsey BW.

Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51. Review.

PMID:
14555458
16.

The cystic fibrosis lung microbiome.

Surette MG.

Ann Am Thorac Soc. 2014 Jan;11 Suppl 1:S61-5. doi: 10.1513/AnnalsATS.201306-159MG.

PMID:
24437409
17.

Correlation between respiratory cultures and sinus cultures in children with cystic fibrosis.

Lavin J, Bhushan B, Schroeder JW Jr.

Int J Pediatr Otorhinolaryngol. 2013 May;77(5):686-9. doi: 10.1016/j.ijporl.2013.01.018. Epub 2013 Feb 13.

PMID:
23415069
18.

Bacterial pattern in chronic sinusitis and cystic fibrosis.

Godoy JM, Godoy AN, Ribalta G, Largo I.

Otolaryngol Head Neck Surg. 2011 Oct;145(4):673-6. doi: 10.1177/0194599811407279. Epub 2011 Apr 26.

PMID:
21521896
19.

[An update on cystic fibrosis for the ENT-specialist].

Rozsasi A, Keck T.

Laryngorhinootologie. 2003 Oct;82(10):715-25; quiz 726-30. German.

PMID:
14593571

Supplemental Content

Support Center